Diabetic retinopathy: modern epidemiological, pathogenetic, diagnostic, surgical aspects (review)
Year: 2022, volume 18 Issue: №4 Pages: 667-671
Heading: Тhematic supplement Article type: Review
Authors: Golovin A.S., Belikova E.I., Kozhukhov A.A., Eskina E.N., Kumar V.
Organization: Peoples' Friendship University of Russia, Leningrad Regional Clinical Hospital, Saint Petersburg, Russia, Academy of Postgraduate Education under the Federal Scientific and Clinical Center of the Federal Medical Biological Agency of Russia
Heading: Тhematic supplement Article type: Review
Authors: Golovin A.S., Belikova E.I., Kozhukhov A.A., Eskina E.N., Kumar V.
Organization: Peoples' Friendship University of Russia, Leningrad Regional Clinical Hospital, Saint Petersburg, Russia, Academy of Postgraduate Education under the Federal Scientific and Clinical Center of the Federal Medical Biological Agency of Russia
Summary:
Abstract. Objective: to present current data regarding the epidemiological, pathogenetic, diagnostic and surgical aspects of proliferative diabetic retinopathy (PDR). The review was performed using the Russian database RSCI and the international database PubMed, while the search keywords were "diabetic retinopathy", "proliferative diabetic retinopathy", "vitrectomy". A total of 478 sources were identified with further use of systematic review filters and authors' knowledge of the topic (43 sources were selected for review). The duration of the search was 10 years (2013-2022). Conclusion. A significant increase in the incidence of diabetes mellitus is accompanied by an increase in the incidence (up to 4% among people with diabetes) of PDR, which is one of the main causes of blindness and low vision in working age. The leading factors that determine the occurrence and pathogenesis of PDR are hyperglycemia, chronic inflammation, and changes in retinal blood flow. In the diagnostic plan, the value of optical coherence tomographic angiogra-phy is noted. The main directions of vitrectomy in PDR (optimization of surgical equipment, visualization of vitreoretinal structures, the use of drugs, the development of new technologies for surgical intervention) provide an increase in the clinical effectiveness of the treatment. The presented modern data should be taken into account when counseling patients about the tactics and duration of treatment for patients with PDR.
Keywords: vitrectomy, diabetes mellitus
Bibliography:
1. Thomas RL, Halim S, Gurudas S, et al. IDF Diabetes Atlas: A review of studies utilising retinal photography on the global prevalence of diabetes related retinopathy between 2015 and 2018. Diabetes Res Clin Pract. 2019; 157 (11): 107840. DOI: 10.101 6/j.diabres.2019.107840.
2. Teo ZL, Tham YC, Yu M, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: Systematic review and meta-analysis. Ophthalmology. 2021; 128 (11): 1580-91. DOI: 10.1016/j.ophtha.2021.04.027.
3. Fursova AZh, Derbeneva AS, Vasilyeva MV. Structural and microvascular changes in the retina and choroid in patients with chronic kidney disease. The Russian Annals of Ophthalmology = Vestnik oftal'mologii. 2021; 137 (6): 99-108.DOI: 10.17116/oftal-ma202113706199.
4. Ghamdi AHA. Clinical predictors of diabetic retinopathy progression: A systematic review. Curr Diabetes Rev. 2020; 16 (3): 242-7. DOI: 10.2174/1573399815666190215120435.
5. Rodrigues M, Xin X, Jee K, et al. VEGF secreted by hy-poxic Muller cells induces MMP-2 expression and activity in endothelial cells to promote retinal neovascularization in prolifera-tive diabetic retinopathy. Diabetes. 2013; 62 (11): 3863-73. DOI: 10.2337/db13-0014.
6. Roy S, Kern TS, Song B, et al. Mechanistic insights into pathological changes in the diabetic retina: implications for targeting diabetic retinopathy. Am J Pathol. 2017; 187 (1): 9-19. DOI: 10.1016/j.ajpath.2016.08.022.
7. Bhatwadekar AD, Shughoury A, Belamkar A, et al. Genetics of diabetic retinopathy, a leading cause of irreversible blindness in the industrialized world. Genes (Basel). 2021; 12 (8): 1200. DOI: 10.3390/genes12081200.
8. Shoshani Y, Harris A, Shoja MM, et al. Impaired ocular blood flow regulation in patients with open-angle glaucoma and diabetes. Clin Exp Ophthalmol. 2012; 40 (7): 697-705. DOI: 10.1111/j.1442-9071.2012.02778.x.
9. Stattin M, Haas A-M, Ahmed D, et al. Detection rate of diabetic macular microaneurysms comparing dye-based angiography and optical coherence tomography angiography Sci Rep. 2020; 10 (1): 16274. DOI: 10.1038/s41598-020-73516-z.
10. Durzhinskaya MH. Microaneurysms as a biomarker of diabetic retinopathy. The Russian Annals of Ophthalmology = Vestnik oftal'mologii. 2021; 137 (5-2): 300-5.
11. Parravano М, De Geronimo D, Scarinci F, et al. Diabetic microaneurysms internal reflectivity on spectral-domain optical coherence tomography and optical coherence tomography angiography detection. Am J Ophthalmol. 2017; 179 (7): 90-6. DOI: 10.1016/j. ajo. 2017.04.021.
12. Querques G, Borrelli E, Battista M, et al. Optical coherence tomography angiography in diabetes: focus on microaneurysms. Eye (Lond). 2021; 35 (1): 142-8. DOI: 10.1038/S41433-020-01173-7.
13. Sahh E, idil SA. Comparison of Quality of Life questionnaires in patients with low vision. Turk J Ophthalmol. 2021; 51 (2): 83-8. DOI: 10.4274/tjo.galenos.2020.99975.
14. Ng H, Vermeer KA, van Meurs JC, La Heij EC. Visual acuity inadequately reflects vision-related quality of life in patients after macula-off retinal detachment surgery. Invest Ophthalmol Vis Sci. 2020; 61 (10): 34. DOI: 10.1167/iovs.61.10.34.
15. Ovechkin IG, Malyshev AV, Karapetov GY, et al. Main principles of the development of the life quality evaluation methods in the case of vitreoretinal pathology. Ophthalmology in Russia. 2015; 12 (4): 75-9.
16. Ovechkin IG, Ovechkin Nl, Pokrovsky DF, et al. Ways to improve the assessment of the "quality of life" in ophthalmology patients — world trends and own experience. Natsional'nyi zhurnal glaucoma. 2022; 21 (3): 58-63.
17. Golovin AS, Belikova El. A comparative qualitative assessment of the severity of diabetic retinopathy in patients with stages III, IV and V, requiring hemodialysis, of chronic renal insufficiency. Russian Ophthalmological Journal. 2022; 15 (4): 18-22. DOI: 10.21516/207 2-0076-2022-15-4-18-22.
18. Stewart MW, Browning DJ, Landers MB. Current management of diabetic tractional retinal detachments. Indian J Ophthalmol. 2018; 66 (12): 1751-62. DOI: 10.4103/ijo. IJOJ217J8.
19. Canan H, Sizmaz S, Altan-Yaycioglu R. Surgical results of combined pars plana vitrectomy and phacoemulsification for vitreous hemorrhage in PDR. Clin Ophthalmol. 2013; (7): 1597-601. DOI: 10.2147/OPTH.S47780.
20. Chen PL, Chen YT, Chen SN. Comparison of 27-gauge and 25-gauge vitrectomy in the management of tractional retinal detachment secondary to proliferative diabetic retinopathy PLoS One. 2021; 25 (16): e0249139. DOI: 10.1371 /journal.pone. 0249139
21. Comaratta M, Hariprasad SM, Reddy R. The evolution of vitreoretinal surgery platforms ophthalmic surgery lasers and imaging retina. 2017; 48 (7): 532-8. DOI: 10.3928/23258160-20170630-03.
22. Egorova EV, Lazareva AK. Vitreolenticular interface. Fyodorov Journal of Ophthalmic Surgery. 2019; (4): 60-6.
23. Introini U, Casalino G. Intravitreal aflibercept in diabetic macular edema: long-term outcomes. Dev Ophthalmol. 2017; 60: 71-77. DOI: 10.1159/000460220.
24. Khan M, Aziz AA, Shafi NA, et al. Targeting angiopoietin in retinal vascular diseases: A literature review and summary of
clinical trials involving Faricimab. Cells. 2020; 9 (8): 1869. DOI: 10.3390/cells9081869.
25. Tong X, Yu Q, Ankawi G, et al. Insights into the role of renal biopsy in patients with T2DM: A literature review of global renal biopsy results. Diabetes Ther. 2020; 11 (9): 1983-99. DOI: 10.1007/sl 3300-020-00888-w.
26. Arrigo A, Teussink M, Aragona E, et al. Multi-color imaging to detect different subtypes of retinal microaneurysms in diabetic retinopathy. Eye (Lond). 2021; 35 (1): 277-81. DOI: 10.1038/S41433-020-0811 -6.
27. Dashina VV. Comprehensive evaluation of the effectiveness of the use of mitochondria-targeted antioxidants to reduce the likelihood of developing cataracts in patients after vitrectomy for the epiretinal membrane. PhD abstract. Moscow, 2020; 22 p.
28. Mansour SE, Browning DJ, Wong К, et al. The evolving treatment of diabetic retinopathy. Clin Ophthalmol. 2020; 4 (14): 653-78. DOI: 10.2147/OPTH.S236637.
29. Deputatova AN. Comprehensive comparative evaluation of various methods of antioxidant therapy during vitrectomy in patients with epiretinal membrane. PhD abstract. Moscow, 2017; 22p.
30. Egorov ЕА. Experience in the use of Retinalamin in various ophthalmic diseases. Russian Medical Journal. Clinical Ophthalmology. 2017; (1): 35-8.
31. Bikbov MM, Fayzrakhmanov RR, Kalanov MR. Combined approach to surgical treatment of patients with proliferative stage of diabetic retinopathy. Saratov Journal of Medical Scientific Research. 2017; 13 (2): 338-45.
32. Bikbov MM, Fayzrakhmanov RR, Zainullin RM, et al. Features of the dynamics of the state of macular pigment and photosensitivity of the central zone of the retina against the background of vitreoretinal surgery in diabetic macular edema. Fyodorov Journal of Ophthalmic Surgery. 2018; (1): 26-30.
33. Bikbov MM, Fayzrakhmanov RR, Kalanov MR, Zainullin RM. Efficiency of vitrectomy in combination with internal limiting membrane peeling associated with the gas-air tampon-ade of the vitreous cavity at the advanced stage of proliferative
diabetic retinopathy. Fyodorov Journal of Ophthalmic Surgery. 2017; (3): 22-6.
34. Gershoni A, Barayev Е, Jbara D, et al. Postoperative complications of combined phacoemulsification and pars plana vitrectomy in diabetic retinopathy patients. Front Med (Lausanne) 2022; 30 (9): 978346. DOI: 10.3389/fmed.2022.978346.
35. Yau GL, Silva PS, Arrigg PG, et al. Postoperative Complications of Pars Plana Vitrectomy for Diabetic Retinal Disease. Semin Ophthalmol. 2018; 33 (1): 126-33. DOI: 10.1080/088205 38.2017.1353832.
36. Berrocal MH, Acaba-Berrocal L. Early pars plana vitrectomy for proliferative diabetic retinopathy: update and review of current literature. Curr Opin Ophthalmol. 2021; 32 (3): 203-8. DOI: 10.1097/ICU.0000000000000760.
37. Schreur V, Brouwers J, Van Huet RAC, et al. Long-term outcomes of vitrectomy for proliferative diabetic retinopathy. Acta Ophthalmol. 2021; 99(1): 83-9. DOI: 10.1111/aos. 14482.
38. El-Baha SM, Ahmed ISH. Trimanual vitrectomy for severe proliferative diabetic retinopathy. Int Ophthalmol. 2021; 41 (5): 1717-27. DOI: 10.1007/s10792-021-01730-3.
39. Yuldasheva NM. Proliferative diabetic retinopathy: new aspects of pathogenesis, substantiation of the system of sparing vitreoretinal surgery and complex pharmacotherapy. DSc dissertation. Moscow, 2014; 308 с
40. Golovin AS, Belikova El. Scientific substantiation, development, evaluation of the safety and clinical efficacy of vitrectomy technology in patients with severe forms of proliferative diabetic retinopathy who are on hemodialysis. Ophthalmology in Russia. 2022; 19 (4): 746-52. DOI: 10.18008/1816-50 95-2022-4-746-752.
41. Medvedev IB, Evgrafov VYu, Batmanov YE. Diabetic retinopathy and its complications. Moscow: GEOTAR-Media, 2015; 288 p.
42. Li Y, Teng D, Shi X, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020; 28 (4): 369: m997. DOI: 10.1136/bmj.m997.
43. Nathan DM, Bebu I, Hainsworth D, et al. Frequency of Evidence-Based Screening for Retinopathy in Type 1 Diabetes. N Engl J Med. 2017; 376 (16): 1507-16. DOI: 10.1056/NEJ-Moa1612836.
| Attachment | Size |
|---|---|
| 2022_04-1_667-671.pdf | 354.55 KB |
Русский
English